 | • レポートコード：D005-00721 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、骨髄線維症治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。骨髄線維症治療の種類別市場規模（輸血、化学療法、アンドロゲン療法）、用途別市場規模（病院、クリニック、骨髄移植センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Incyte、AllCells、Mylan Pharmaceuticals、Novartis、Taro Pharmaceuticals、Celgene、ATCC、Eli Lilly、Bristol-Myers Squibb、Lonza Group ・地域別グローバル市場分析 2015年-2020年 ・骨髄線維症治療の北米市場（アメリカ、カナダ、メキシコ） ・骨髄線維症治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・骨髄線維症治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・骨髄線維症治療の南米市場（ブラジル、アルゼンチン） ・骨髄線維症治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：輸血、化学療法、アンドロゲン療法 ・用途別分析：病院、クリニック、骨髄移植センター ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Myelofibrosis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 683.4 million by 2025, from USD 592 million in 2019.
The Myelofibrosis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Myelofibrosis Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Myelofibrosis Treatment market has been segmented into:
Blood Transfusion
Chemotherapy
Androgen Therapy
By Application, Myelofibrosis Treatment has been segmented into:
Hospitals
Clinics
Bone Marrow Transplant Centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Myelofibrosis Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Myelofibrosis Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Myelofibrosis Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Myelofibrosis Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Myelofibrosis Treatment Market Share Analysis
Myelofibrosis Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Myelofibrosis Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Myelofibrosis Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Myelofibrosis Treatment are:
Incyte
AllCells
Mylan Pharmaceuticals
Novartis
Taro Pharmaceuticals
Celgene
ATCC
Eli Lilly
Bristol-Myers Squibb
Lonza Group
Table of Contents
1 Myelofibrosis Treatment Market Overview
1.1 Product Overview and Scope of Myelofibrosis Treatment
1.2 Classification of Myelofibrosis Treatment by Type
1.2.1 Global Myelofibrosis Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Myelofibrosis Treatment Revenue Market Share by Type in 2019
1.2.3 Blood Transfusion
1.2.4 Chemotherapy
1.2.5 Androgen Therapy
1.3 Global Myelofibrosis Treatment Market by Application
1.3.1 Overview: Global Myelofibrosis Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Bone Marrow Transplant Centers
1.4 Global Myelofibrosis Treatment Market by Regions
1.4.1 Global Myelofibrosis Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Myelofibrosis Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Myelofibrosis Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Myelofibrosis Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Myelofibrosis Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Myelofibrosis Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Myelofibrosis Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Incyte
2.1.1 Incyte Details
2.1.2 Incyte Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Incyte SWOT Analysis
2.1.4 Incyte Product and Services
2.1.5 Incyte Myelofibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 AllCells
2.2.1 AllCells Details
2.2.2 AllCells Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AllCells SWOT Analysis
2.2.4 AllCells Product and Services
2.2.5 AllCells Myelofibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mylan Pharmaceuticals
2.3.1 Mylan Pharmaceuticals Details
2.3.2 Mylan Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Mylan Pharmaceuticals SWOT Analysis
2.3.4 Mylan Pharmaceuticals Product and Services
2.3.5 Mylan Pharmaceuticals Myelofibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Myelofibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Taro Pharmaceuticals
2.5.1 Taro Pharmaceuticals Details
2.5.2 Taro Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Taro Pharmaceuticals SWOT Analysis
2.5.4 Taro Pharmaceuticals Product and Services
2.5.5 Taro Pharmaceuticals Myelofibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Celgene
2.6.1 Celgene Details
2.6.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Celgene SWOT Analysis
2.6.4 Celgene Product and Services
2.6.5 Celgene Myelofibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 ATCC
2.7.1 ATCC Details
2.7.2 ATCC Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 ATCC SWOT Analysis
2.7.4 ATCC Product and Services
2.7.5 ATCC Myelofibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly SWOT Analysis
2.8.4 Eli Lilly Product and Services
2.8.5 Eli Lilly Myelofibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bristol-Myers Squibb
2.9.1 Bristol-Myers Squibb Details
2.9.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bristol-Myers Squibb SWOT Analysis
2.9.4 Bristol-Myers Squibb Product and Services
2.9.5 Bristol-Myers Squibb Myelofibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Lonza Group
2.10.1 Lonza Group Details
2.10.2 Lonza Group Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Lonza Group SWOT Analysis
2.10.4 Lonza Group Product and Services
2.10.5 Lonza Group Myelofibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Myelofibrosis Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Myelofibrosis Treatment Players Market Share
3.2.2 Top 10 Myelofibrosis Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Myelofibrosis Treatment Revenue and Market Share by Regions
4.2 North America Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
5 North America Myelofibrosis Treatment Revenue by Countries
5.1 North America Myelofibrosis Treatment Revenue by Countries (2015-2020)
5.2 USA Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
6 Europe Myelofibrosis Treatment Revenue by Countries
6.1 Europe Myelofibrosis Treatment Revenue by Countries (2015-2020)
6.2 Germany Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
6.4 France Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Myelofibrosis Treatment Revenue by Countries
7.1 Asia-Pacific Myelofibrosis Treatment Revenue by Countries (2015-2020)
7.2 China Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
7.5 India Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
8 South America Myelofibrosis Treatment Revenue by Countries
8.1 South America Myelofibrosis Treatment Revenue by Countries (2015-2020)
8.2 Brazil Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Myelofibrosis Treatment by Countries
9.1 Middle East & Africa Myelofibrosis Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Myelofibrosis Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Myelofibrosis Treatment Market Forecast by Type (2019-2024)
10.3 Blood Transfusion Revenue Growth Rate (2015-2025)
10.4 Chemotherapy Revenue Growth Rate (2015-2025)
10.5 Androgen Therapy Revenue Growth Rate (2015-2025)
11 Global Myelofibrosis Treatment Market Segment by Application
11.1 Global Myelofibrosis Treatment Revenue Market Share by Application (2015-2020)
11.2 Myelofibrosis Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Bone Marrow Transplant Centers Revenue Growth (2015-2020)
12 Global Myelofibrosis Treatment Market Size Forecast (2021-2025)
12.1 Global Myelofibrosis Treatment Market Size Forecast (2021-2025)
12.2 Global Myelofibrosis Treatment Market Forecast by Regions (2021-2025)
12.3 North America Myelofibrosis Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Myelofibrosis Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Myelofibrosis Treatment Revenue Market Forecast (2021-2025)
12.6 South America Myelofibrosis Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Myelofibrosis Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Myelofibrosis Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Myelofibrosis Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Myelofibrosis Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Myelofibrosis Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Incyte Corporate Information, Location and Competitors
Table 6. Incyte Myelofibrosis Treatment Major Business
Table 7. Incyte Myelofibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Incyte SWOT Analysis
Table 9. Incyte Myelofibrosis Treatment Product and Solutions
Table 10. Incyte Myelofibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. AllCells Corporate Information, Location and Competitors
Table 12. AllCells Myelofibrosis Treatment Major Business
Table 13. AllCells Myelofibrosis Treatment Total Revenue (USD Million) (2018-2019)
Table 14. AllCells SWOT Analysis
Table 15. AllCells Myelofibrosis Treatment Product and Solutions
Table 16. AllCells Myelofibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Mylan Pharmaceuticals Corporate Information, Location and Competitors
Table 18. Mylan Pharmaceuticals Myelofibrosis Treatment Major Business
Table 19. Mylan Pharmaceuticals Myelofibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Mylan Pharmaceuticals SWOT Analysis
Table 21. Mylan Pharmaceuticals Myelofibrosis Treatment Product and Solutions
Table 22. Mylan Pharmaceuticals Myelofibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis Myelofibrosis Treatment Major Business
Table 25. Novartis Myelofibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis Myelofibrosis Treatment Product and Solutions
Table 28. Novartis Myelofibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Taro Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Taro Pharmaceuticals Myelofibrosis Treatment Major Business
Table 31. Taro Pharmaceuticals Myelofibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Taro Pharmaceuticals SWOT Analysis
Table 33. Taro Pharmaceuticals Myelofibrosis Treatment Product and Solutions
Table 34. Taro Pharmaceuticals Myelofibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Celgene Corporate Information, Location and Competitors
Table 36. Celgene Myelofibrosis Treatment Major Business
Table 37. Celgene Myelofibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Celgene SWOT Analysis
Table 39. Celgene Myelofibrosis Treatment Product and Solutions
Table 40. Celgene Myelofibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. ATCC Corporate Information, Location and Competitors
Table 42. ATCC Myelofibrosis Treatment Major Business
Table 43. ATCC Myelofibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 44. ATCC SWOT Analysis
Table 45. ATCC Myelofibrosis Treatment Product and Solutions
Table 46. ATCC Myelofibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Eli Lilly Corporate Information, Location and Competitors
Table 48. Eli Lilly Myelofibrosis Treatment Major Business
Table 49. Eli Lilly Myelofibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Eli Lilly SWOT Analysis
Table 51. Eli Lilly Myelofibrosis Treatment Product and Solutions
Table 52. Eli Lilly Myelofibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 54. Bristol-Myers Squibb Myelofibrosis Treatment Major Business
Table 55. Bristol-Myers Squibb Myelofibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Bristol-Myers Squibb SWOT Analysis
Table 57. Bristol-Myers Squibb Myelofibrosis Treatment Product and Solutions
Table 58. Bristol-Myers Squibb Myelofibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Lonza Group Corporate Information, Location and Competitors
Table 60. Lonza Group Myelofibrosis Treatment Major Business
Table 61. Lonza Group Myelofibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Lonza Group SWOT Analysis
Table 63. Lonza Group Myelofibrosis Treatment Product and Solutions
Table 64. Lonza Group Myelofibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Myelofibrosis Treatment Revenue (Million USD) by Players (2015-2020)
Table 66. Global Myelofibrosis Treatment Revenue Share by Players (2015-2020)
Table 67. Global Myelofibrosis Treatment Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Myelofibrosis Treatment Revenue Market Share by Regions (2015-2020)
Table 69. North America Myelofibrosis Treatment Revenue by Countries (2015-2020)
Table 70. North America Myelofibrosis Treatment Revenue Market Share by Countries (2015-2020)
Table 71. Europe Myelofibrosis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Myelofibrosis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Myelofibrosis Treatment Revenue by Countries (2015-2020)
Table 74. South America Myelofibrosis Treatment Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Myelofibrosis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Myelofibrosis Treatment Revenue Market Share by Countries (2015-2020)
Table 77. Global Myelofibrosis Treatment Revenue (Million USD) by Type (2015-2020)
Table 78. Global Myelofibrosis Treatment Revenue Share by Type (2015-2020)
Table 79. Global Myelofibrosis Treatment Revenue Forecast by Type (2021-2025)
Table 80. Global Myelofibrosis Treatment Revenue by Application (2015-2020)
Table 81. Global Myelofibrosis Treatment Revenue Share by Application (2015-2020)
Table 82. Global Myelofibrosis Treatment Revenue Forecast by Application (2021-2025)
Table 83. Global Myelofibrosis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Myelofibrosis Treatment Picture
Figure 2. Global Myelofibrosis Treatment Revenue Market Share by Type in 2019
Figure 3. Blood Transfusion Picture
Figure 4. Chemotherapy Picture
Figure 5. Androgen Therapy Picture
Figure 6. Myelofibrosis Treatment Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Bone Marrow Transplant Centers Picture
Figure 10. Global Myelofibrosis Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Myelofibrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Myelofibrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Myelofibrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Myelofibrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Myelofibrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Myelofibrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Myelofibrosis Treatment Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Myelofibrosis Treatment Revenue Market Share in 2019
Figure 19. Global Top 10 Players Myelofibrosis Treatment Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Myelofibrosis Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Myelofibrosis Treatment Revenue Market Share by Regions (2015-2020)
Figure 23. Global Myelofibrosis Treatment Revenue Market Share by Regions in 2018
Figure 24. North America Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Europe Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 27. South America Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 29. North America Myelofibrosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 30. North America Myelofibrosis Treatment Revenue Market Share by Countries in 2019
Figure 31. USA Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Canada Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Europe Myelofibrosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Myelofibrosis Treatment Revenue Market Share by Countries in 2019
Figure 36. Germany Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 37. UK Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 38. France Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Russia Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Italy Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Myelofibrosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Myelofibrosis Treatment Revenue Market Share by Countries in 2019
Figure 43. China Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Japan Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Korea Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 46. India Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 48. South America Myelofibrosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 49. South America Myelofibrosis Treatment Revenue Market Share by Countries in 2019
Figure 50. Brazil Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Myelofibrosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Myelofibrosis Treatment Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 55. UAE Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Myelofibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Global Myelofibrosis Treatment Revenue Share by Type (2015-2020)
Figure 59. Global Myelofibrosis Treatment Revenue Share by Type in 2019
Figure 60. Global Myelofibrosis Treatment Market Share Forecast by Type (2021-2025)
Figure 61. Global Blood Transfusion Revenue Growth Rate (2015-2020)
Figure 62. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 63. Global Androgen Therapy Revenue Growth Rate (2015-2020)
Figure 64. Global Myelofibrosis Treatment Revenue Share by Application (2015-2020)
Figure 65. Global Myelofibrosis Treatment Revenue Share by Application in 2019
Figure 66. Global Myelofibrosis Treatment Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Bone Marrow Transplant Centers Revenue Growth Rate (2015-2020)
Figure 70. Global Myelofibrosis Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Myelofibrosis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Myelofibrosis Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Myelofibrosis Treatment Revenue Market Forecast (2021-2025)
Figure 74. Europe Myelofibrosis Treatment Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Myelofibrosis Treatment Revenue Market Forecast (2021-2025)
Figure 76. South America Myelofibrosis Treatment Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Myelofibrosis Treatment Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
化学療法誘発性好中球減少症（CIN）治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Chemotherapy-Induced Neutropenia (CIN) Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. …- 多形神経膠芽腫治療（GBM）の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Glioblastoma Multiforme Treatment (GBM) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.1% in the forecast period of 2020 to 2025 and will expected to reach USD 755.3 million by 2025, from USD 643.9 million in 2019. Th…
- 化学療法誘発末梢神経障害治療の世界市場レポート2020 CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling of the hands and feet, severe pain, numbness and muscle weakness, all of which can occur during cancer treatment, and frequently persist after chemother…
- 前立腺がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Prostate Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prostate Cancer Tre…
- 圧縮空気処理装置の世界市場レポート2020 Compressed Air Treatment Equipment is engineered to work specifically with rotary screw and reciprocating compressors. Compressed air applications range from general purpose shop air to breathing air-with a wide range of applications in between. Market Analysis and Insights: Global Compressed Air Tr…